Corporate Board Profile
Tech Score: 67/100
2 mention(s) identify JULIE XING as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| APTARGROUP, INC. | 2023-03-24 | Ms. Xing served as Senior Director, Global New Product Planning and Payer Marketing, Pricing, Reimbursement and Access of Lilly Diabetes; Vice President and General Manager of Asia Pacific and Japan Operations at Panomics and Affymetrix. | Held leadership roles in pharmaceutical and dental equipment companies with responsibilities including Global New Product Planning and Market Access; served as Vice President and General Manager at Panomics and Affymetrix, companies known for technology and scientific products, indicating technical expertise. |
| APTARGROUP, INC. | 2025-03-28 | Dr. Xing has a PhD in biology from the Hong Kong University of Science and Technology... She was General Manager and China President of Illumina (a global next generation gene sequencer company) from 2005 to 2007. Prior to Eli Lilly, from 2007 to 2010 Dr. Xing was Vice President and General Manager of Asia Pacific and Japan Operations at Panomics and Affymetrix, which was acquired by Thermo Fisher Scientific. | She has a PhD in biology and has held leadership roles in pharmaceutical and biotechnology companies, including roles at Illumina, a global next generation gene sequencer company, and Panomics and Affymetrix, which are technology companies. This indicates technical expertise likely including software-related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2023-03-24 | Ms. Xing served as Senior Director, Global New Product Planning and Payer Marketing, Pricing, Reimbursement and Access of Lilly Diabetes; Vice President and General Manager of Asia Pacific and Japan Operations at Panomics and Affymetrix. |
| 2024-03-22 | Ms. Xing has served as Executive Chair of the Board of Directors of Mundipharma China since 2022. Mundipharma is a multinational pharmaceutical leader. From 2019 to 2022, Ms. Xing held the position of Global Senior Vice President, President of Greater China for Envista Holdings Corporation (a dental equipment and supplies company). |
| 2025-03-28 | Dr. Xing has a PhD in biology from the Hong Kong University of Science and Technology... She was General Manager and China President of Illumina (a global next generation gene sequencer company) from 2005 to 2007. Prior to Eli Lilly, from 2007 to 2010 Dr. Xing was Vice President and General Manager of Asia Pacific and Japan Operations at Panomics and Affymetrix, which was acquired by Thermo Fisher Scientific. |
Data sourced from SEC filings. Last updated: 2025-10-12